Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Shire plc. (12/15/15). "Press Release: Shire to Present at 34th Annual J.P. Morgan Healthcare Conference". Lexington, MA. 2015-12-15
AstraZeneca plc. (12/14/15). "Press Release: Discussions with Acerta Pharma BV". 2015-12-14
Premaitha Health plc. (12/14/15). "Press Release: Premaitha Health Signs Investment Agreement with Thermo Fisher Scientific". Manchester. 2015-12-14
Blue Scientific Ltd.. (12/11/15). "Press Release: Parallel Imaging MS/MS Installed at Maastricht University M4I". 2015-12-11
Freeline Therapeutics Ltd.. (12/10/15). "Press Release: Syncona and UCLB Launch Freeline Therapeutics to Develop Gene Therapies for Bleeding Disorders". London. 2015-12-10
[iito] Business Intelligence. (12/9/15). "Press Release: Launches Today. New Business Web Portal for the UK and Irish Life Sciences Targets Decision Makers World-wide". Bremen & London. 2015-12-09
4D Pharma plc. (12/8/15). "Press Release: Placing to Raise £30 Million by the Issue of 3,797,469 New Ordinary Shares at 790p per Share". 2015-12-08
Key Organics Ltd.. (12/7/15). "Press Release: New Bionet 2nd Generation Premium Fragment Library". 2015-12-07
Bruker Corporation. (12/7/15). "Press Release: Bruker Introduces MetaboScape at MetaboMeeting 2015. Novel MetaboScape Software Links Experimental Data to Biology by Pathway Mapping". Cambridge. 2015-12-07
Cypralis Ltd.. (12/7/15). "Press Release: Cypralis Limited Announces Collaboration with Johnson & Johnson Innovation in the Field of Neurodegenerative Diseases". Ongar. 2015-12-07
Porvair plc. (12/7/15). "Press Release: Pre-close Trading Update and Acquisition". 2015-12-07
Auspherix Ltd.. (12/5/15). "Press Release: Auspherix Appoints Dr. Neil Miller as Chief Scientific Officer". Cambridge & Stevenage. 2015-12-05
Oxford Immunotec Global plc. (12/3/15). "Press Release: Oxford Immunotec Announces Availability of the T-SPOT.PRT Test in the United States". Oxford & Marlborough, MA. 2015-12-03
Kesios Therapeutics Ltd.. (12/2/15). "Press Release: Kesios Therapeutics Raises £19 Million in Series A Financing. Builds Management Team Led by Dr. Paolo Paoletti as CEO". London. 2015-12-02
Microsaic Systems plc. (12/2/15). "Press Release: Trading Update and Directorate Changes". 2015-12-02
Adaptimmune Therapeutics plc. (12/1/15). "Press Release: Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies". Philadeliphia, PA & Oxford. 2015-12-01
Protagen AG. (12/1/15). "Press Release: Protagen AG Joins MATURA Consortium to Support Identification of Treatment Response Predictors in Rheumatoid Arthritis (RA)". 2015-12-01
MedDay Pharmaceuticals S.A.S.. (12/1/15). "Press Release: MedDay Provides Update on MS-ON Study of MD-1003". Paris. 2015-12-01
Titian Software Ltd.. (12/1/15). "Press Release: Titian Focuses on Bringing Sample Management Solutions to Any Size of Organisation with New Appointments and Options". London. 2015-12-01
Qiagen N.V.. (12/1/15). "Press Release: Qiagen’s QuantiFERON-TB Test Chosen for Use in England Tender". Hilden. 2015-12-01
Heptares Therapeutics Ltd.. (11/30/15). "Press Release: Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas". London & Boston, MA. 2015-11-30
Biopta Ltd.. (11/25/15). "Press Release: ReproCell Acquires Biopta to Expand Its Drug Discovery Services". Glasgow. 2015-11-25
GlaxoSmithKline plc. (11/25/15). "Press Release: GSK Announces Start of Phase III Study of Sirukumab in Giant Cell Arteritis". London. 2015-11-25
Horizon Discovery Group plc. (11/25/15). "Press Release: Horizon Discovery Group plc Signs Three Diagnostic Agreements Worth an Initial $3.3 Million". Cambridge. 2015-11-25
Heptares Therapeutics Ltd.. (11/25/15). "Press Release: Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-molecule CGRP Antagonists for Treatment of Migraine". Jerusalem & London. 2015-11-25
ReproCell, Inc.. (11/24/15). "Press Release: Regarding the Synergy Effect of Making Biopta Limited a Wholly-owned Subsidiary". 2015-11-24
Adaptimmune Therapeutics plc. (11/24/15). "Press Release: Adaptimmune Initiates Phase I / II trial Evaluating its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients with the Most Common Type of Lung Cancer". Oxford & Philadelphia, PA. 2015-11-24
Horizon Discovery Group plc. (11/24/15). "Press Release: Horizon Discovery Group plc and Axol Bioscience Ltd Announce Strategic Partnership". Cambridge. 2015-11-24
Abzena plc. (11/24/15). "Press Release: Placing to Raise £20 Million and Acquisition [Not for United States, Australia, Canada, Japan, the Republic of Ireland, the Republic of South Africa, et al.] ". Cambridge. 2015-11-24
Abzena plc. (11/24/15). "Press Release: Half Year Results – Delivery, Acquisition and Growth". Cambridge. 2015-11-24
Randox Laboratories Ltd.. (11/23/15). "Press Release: Randox Laboratories and Biosytems International Announce Completion of Clinical Trial and Licencing for QuantiPlasma Antibodies for Early Lung Cancer Diagnostics". 2015-11-23
Gurnet Point Capital. (11/19/15). "Press Release: Gurnet Point Capital Launches New Drug Development Company, Boston Pharmaceuticals, with $600 Million Commitment". Cambridge, MA. 2015-11-19
Boston Pharmaceuticals. (11/19/15). "Press Release: Boston Pharmaceuticals Appoints Santiago Arroyo, M.D., Ph.D., as Chief Medical Officer and Constantine Chinoporos, as Chief Business Officer". Cambridge, MA. 2015-11-19
Faron Pharmaceuticals Oy. (11/17/15). "Press Release: Admission to AIM and First Day of Dealings. £10 million Fundraise to Progress Phase III Clinical Trial [Not for US, AU, CA, JP, ZA, IE or any other jurisdiction where unlawful]". 2015-11-17
MGB Biopharma Ltd.. (11/17/15). "Press Release: MGB Biopharma Successfully Completes Feasibility Study with Topical Formulation of its Lead Antibacterial MGB-BP-3". Glasgow. 2015-11-17
Axol Bioscience Ltd.. (11/16/15). "Press Release: Axol Bioscience Appoints Chief Business Officer". 2015-11-16
Adaptimmune Therapeutics plc. (11/13/15). "Press Release: Adaptimmune Reports First Quarter Financial Results for Fiscal Year 2015-16". Philadeliphia, PA & Oxford. 2015-11-13
Thermo Fisher Scientific Inc.. (11/13/15). "Press Release: Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes". Waltham, MA. 2015-11-13
Mylan N.V.. (11/13/15). "Press Release: Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer". Hertfordshire & Pittsburgh, PA. 2015-11-13
Roche. (11/12/15). "Press Release: Roche to Restructure Its Manufacturing Network for Small Molecules". Basel. 2015-11-12
NightstaRx Ltd.. (11/12/15). "Press Release: NightstaRx Announces the Start of a Miami Gene Therapy Study to Treat Choroideremia". London. 2015-11-12
Genomics England Ltd.. (11/12/15). "Press Release: Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and Cancer". London, et al.. 2015-11-12
Adaptimmune Therapeutics plc. (11/12/15). "Press Release: Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference". Philadeliphia, PA & Oxford. 2015-11-12
Uniqure N.V.. (11/12/15). "Press Release: Uniqure to Present at the Jefferies 2015 Global Healthcare Conference – London". Amsterdam. 2015-11-12
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
Evotec AG. (11/11/15). "Press Release: Evotec to Present at Two Upcoming IR Conferences in November". Hamburg. 2015-11-11
Affimed N.V.. (11/11/15). "Press Release: Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference – London". Heidelberg. 2015-11-11
Novasep S.A.. (11/10/15). "Press Release: Novasep and CPI Advance Innovation in UK Biopharmaceutical Manufacturing". Pompey. 2015-11-10
Abzena plc. (11/10/15). "Press Release: Appointment of Campbell Bunce as Senior Vice President, Scientific Operations". Cambridge. 2015-11-10
NightstaRx Ltd.. (11/9/15). "Press Release: NightstaRx Closes $35 Million Series B Funding to Advance Inherited Retinal Disease Pipeline". London. 2015-11-09
AstraZeneca plc. (11/6/15). "Press Release: AstraZeneca Strengthens Cardiovascular and Metabolic disease Portfolio with Acquisition of ZS Pharma". 2015-11-06
Blue Scientific Ltd.. (11/6/15). "Press Release: Blue Scientific Now Represents Bruker Nano Surfaces in Norway, Sweden, Denmark and Finland". 2015-11-06
Adaptimmune Therapeutics plc. (11/5/15). "Press Release: Adaptimmune Announces Data from Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)". Philadel 2015-11-05
Desktop Genetics Ltd.. (11/5/15). "Press Release: Our Partnership with Transcriptic". London. 2015-11-05
Apta Biosciences Ltd.. (11/4/15). "Press Release: Apta Biosciences Awarded H2020 EU Grant to Incorporate Seligo Technology into Next Generation Antibiotics and Infectious Disease Therapeutics". London. 2015-11-04
Genomics England Ltd.. (11/4/15). "Press Release: Genomics England Selects Cognizant as a Technology Partner for the 100,000 Genomes Project". 2015-11-04
GlaxoSmithKline plc. (11/4/15). "Press Release: GSK’s Nucala (mepolizumab) Receives Approval from US FDA". London. 2015-11-04
Horizon Discovery Group plc. (11/4/15). "Press Release: Horizon Discovery Introduces Cell Free DNA HDx Reference Standards". Cambridge. 2015-11-04
ReViral Ltd.. (11/4/15). "Press Release: ReViral Are Delighted to Announce the Appointment of Dr Rachel Harland to the Post of COO in the Company’s Management Team". 2015-11-04
Merck KGaA. (11/3/15). "Press Release: Merck’s Glucophage Extended Release (XR) Can be Used for More Type 2 Diabetes Patients". Darmstadt. 2015-11-03
GlaxoSmithKline plc. (11/3/15). "Press Release: GSK Profiles Innovative R&D Portfolio to Investors. 40 Potential New Medicines and Vaccines". London. 2015-11-03
Almac Group Ltd.. (11/3/15). "Press Release: Almac Acquires Arran Chemical Company and Expands Biocatalysis Services". Craigavon. 2015-11-03
BioCity Nottingham. (11/2/15). "Press Release: BioCity Appoints New Chief Financial Officer". 2015-11-02
BioCity Scotland. (11/2/15). "Press Release: Alfacyte Ltd Moves to BioCity Scotland After Securing £350k of Investment in Peanut Allergy Vaccine". 2015-11-02
Shire plc. (11/2/15). "Press Release: Shire to Acquire Dyax Corp, Expanding and Extending Industry-leading Hereditary Angioedema (HAE) Portfolio". Dublin & Burlington, MA. 2015-11-02
DNA Electronics Ltd.. (11/2/15). "Press Release: DNAe £25 Million ($38 Million) Bank Facility to Fund Development of Pioneering Point-of-Need IVD for Serious Blood Infections". London & Albuquerque, NM. 2015-11-02
Genomics England Ltd.. (10/29/15). "Press Release: Northern Ireland Joins the 100,000 Genomes Project". 2015-10-29
AB Sciex (d/b/a Sciex). (10/28/15). "Press Release: Sciex Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine". Framingham, MA. 2015-10-28
Catapult UK. (10/26/15). "Press Release: Initial Six Centres of Excellence in UK PM Network Named. Teams in Belfast, Cardiff, Glasgow, Leeds, Manchester & Oxford". London. 2015-10-26
Metrion Biosciences Ltd.. (10/22/15). "Press Release: Metrion Biosciences Becomes Independent CRO. Management Team Completes Buyout of Specialist Ion Channel Research Business from Xention". Cambridge. 2015-10-22
Domainex Ltd.. (10/20/15). "Press Release: Domainex and Imperial College London Partner to Discover New Therapies to Treat Myocardial Infarction". 2015-10-20
Genomics plc. (10/19/15). "Press Release: Genomics plc Signs Collaboration Agreement with Oxford University and the Oxford University Hospitals NHS Trust". Oxford. 2015-10-19
Microsaic Systems plc. (10/19/15). "Press Release: Results of General Meeting and Completion of Placing". 2015-10-19
Grifols S.A.. (10/22/15). "Press Release: Grifols Official Opening of the Bioscience Division New Worldwide Operations Facility in Ireland". Barcelona & Dublin. 2015-10-15
Microsaic Systems plc. (10/15/15). "Press Release: Additional Demand Option Exercise". 2015-10-15
Adaptimmune Therapeutics plc. (10/13/15). "Press Release: Adaptimmune Reports Full Fiscal Year 2015 Financial Results". Philadeliphia, PA & Oxford. 2015-10-13
Thermo Fisher Scientific Inc.. (10/13/15). "Press Release: Thermo Fisher Scientific Manufacturing Site First in Forensic Industry to Meet Proposed Guidelines for ISO 18385 Certification". South San Francisco, CA. 2015-10-13
Adaptimmune Therapeutics plc. (10/9/15). "Press Release: Adaptimmune Growth Leads to Long-term Expansion Plans in Philadelphia. Company Selects The Navy Yard as Site for U.S. Headquarters and Base for Clinical and Manufacturing Operations". Philadeliphia 2015-10-09
Abzena plc. (10/9/15). "Press Release: Adheron Therapeutics Is Acquired by Roche for Its Therapeutic Antibody. Antibody Fully Humanised Using Abzena’s Proprietary Technology". Cambridge. 2015-10-09
Oxford BioTherapeutics Ltd.. (10/8/15). "Press Release: Oxford BioTherapeutics Appoints Shawn Tomasello to Its Board of Directors". Oxford & San Jose, CA. 2015-10-08
Adaptimmune Therapeutics plc. (10/6/15). "Press Release: Adaptimmune Announces New Research and Development Facility in Oxfordshire". Oxford & Philadelphia, PA. 2015-10-06
Genomics plc. (10/5/15). "Press Release: Genomics plc Previews Its Integrated Platform on Genetic Association at ASHG 2015 Annual Meeting". Oxford. 2015-10-05
Genomics plc. (10/1/15). "Press Release: Genomics plc Signs Collaboration Agreement with Biogen". Oxford. 2015-10-01
Genomics England Ltd.. (9/30/15). "Press Release: Genomics England Announces Interpretation Partners and Expands Industry Engagement". 2015-09-30
Microsaic Systems plc. (9/30/15). "Press Release: Interim Results". 2015-09-30
Microsaic Systems plc. (9/30/15). "Press Release: Placing of up to 9,661,588 New Ordinary Shares and Option to Place up to a Further 8,520,230 New Ordinary Shares at 33 Pence per Share and Notice of General Meeting [not for US, AU, CA, JP, NZ, IE, ZA et 2015-09-30
Zinc Ahead Ltd.. (9/29/15). "Press Release: Veeva Systems Acquires Zinc Ahead. Leading Providers Join to Deliver the Most Complete Commercial Content Management Solution for the Life Sciences Industry". Pleasanton, CA & Oxford. 2015-09-29
Heptares Therapeutics Ltd.. (9/28/15). "Press Release: Heptares Awarded $5.5 Million Research & Development Grant From the US National Institute on Drug Abuse (NIDA)". London & Boston, MA. 2015-09-28
Cobra Biologics Ltd.. (9/24/15). "Press Release: Cobra Biologics and the University of Manchester Announce Collaboration to Improve Industrial Scale-up". Keele & Manchester. 2015-09-24
Genomics England Ltd.. (9/24/15). "Press Release: Garvan Partners with Genomics England to Advance Genomic Medicine". 2015-09-24
Intertek Group plc. (9/23/15). "Press Release: Intertek Opens New 10,000 ft² Biologic Medicine Contract Services Laboratory in Manchester, UK". Manchester. 2015-09-23
Nerre Therapeutics Ltd.. (9/23/15). "Press Release: Dr Mary Kerr to Join NeRRe Therapeutics as CEO". Stevenage. 2015-09-23
Horizon Discovery Group plc. (9/22/15). "Press Release: Interim Results for the Six Months Ended 30 June 2015. Strong Revenue Growth and Investment in our Strategy for Scale". Cambridge. 2015-09-22
Bicycle Therapeutics Ltd.. (9/21/15). "Press Release: Bicycle Therapeutics Announces the Appointment of Dr. Kevin Lee as Chief Executive Officer". Cambridge. 2015-09-21
Auspherix Ltd.. (9/17/15). "Press Release: Auspherix and Domainex Expand Collaboration to Develop New Drugs that Tackle Antibiotic-Resistant Bacterial Infections". Cambridge & Stevenage. 2015-09-17
Quethera Ltd.. (9/17/15). "Press Release: Quethera Announces Seed Financing to Develop Gene Therapy Aimed at Preventing Blindness in Glaucoma Patients". Cambridge. 2015-09-17
Catapult Ventures. (9/16/15). "Press Release: Catapult Ventures Announces the Acquisition of Lumora by Erba Diagnostics Mannheim". 2015-09-16
Horizon Discovery Group plc. (9/16/15). "Press Release: Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc.". Cambridge. 2015-09-16
Zeltia S.A.. (9/15/15). "Press Release: PharmaMar Opens New Affiliate in UK". Madrid. 2015-09-15
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top